We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

169 hedge funds and large institutions have $282M invested in Spectrum Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

1% more funds holding

Funds holding: 167169 (+2)

2% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 51

8% less call options, than puts

Call options by funds: $5.65M | Put options by funds: $6.12M

60% less capital invested

Capital invested by funds: $708M → $282M (-$426M)

Holders
169
Holders Change
+2
Holders Change %
+1.2%
% of All Funds
3.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
52
Reduced
51
Closed
21
Calls
$5.65M
Puts
$6.12M
Net Calls
-$470K
Net Calls Change
+$9.68M
Name Holding Trade Value Shares
Change
Change in
Stake
MSL
51
Mackay Shields LLC
New York
$465K -$132K -16,300 -11%
Hudson Bay Capital Management
52
Hudson Bay Capital Management
Connecticut
$455K +$1.01M +125,000 New
TCM
53
Tekla Capital Management
Massachusetts
$417K
Two Sigma Advisers
54
Two Sigma Advisers
New York
$391K -$158K -19,500 -15%
CAM
55
Congress Asset Management
Massachusetts
$381K -$235K -29,065 -22%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$366K -$109K -13,500 -12%
Ensign Peak Advisors
57
Ensign Peak Advisors
Utah
$359K +$796K +98,500 New
Squarepoint
58
Squarepoint
New York
$358K -$222K -27,507 -22%
CS
59
Credit Suisse
Switzerland
$338K +$9.64K +1,193 +1%
VOYA Investment Management
60
VOYA Investment Management
Georgia
$332K -$7.64M -945,684 -91%
Thrivent Financial for Lutherans
61
Thrivent Financial for Lutherans
Minnesota
$327K +$2.3K +285 +0.3%
SOADOR
62
State of Alaska Department of Revenue
Alaska
$310K -$11.2K -1,392 -2%
Rafferty Asset Management
63
Rafferty Asset Management
New York
$306K -$321K -39,775 -32%
UBS AM
64
UBS AM
Illinois
$298K +$102K +12,650 +18%
AIG
65
American International Group
New York
$294K -$17.5K -2,171 -3%
TPSF
66
Texas Permanent School Fund
Texas
$281K +$3.72K +460 +0.6%
Citadel Advisors
67
Citadel Advisors
Florida
$281K +$423K +52,383 +211%
PI
68
PineBridge Investments
New York
$279K -$333K -41,169 -35%
Comerica Bank
69
Comerica Bank
Texas
$277K +$2.58K +319 +0.3%
ASRS
70
Arizona State Retirement System
Arizona
$274K -$462K -57,212 -43%
State of Tennessee, Department of Treasury
71
State of Tennessee, Department of Treasury
Tennessee
$269K -$45.5K -5,632 -7%
SDIC
72
South Dakota Investment Council
South Dakota
$254K
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$247K -$21.8K -2,692 -4%
KBC Group
74
KBC Group
Belgium
$244K
ERSOT
75
Employees Retirement System of Texas
Texas
$237K

SPPI Hedge Fund Activity: Q4 2019 in Review

169 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2019, worth a combined $282M — down 60% from $708M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 21 closed out — a net gain of 8 holders — while 52 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $9.99M. The largest seller was Primecap Management, cutting an estimated $36.8M.

  • 169 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $282M of Spectrum Pharmaceuticals Inc stock for Q4 2019, down 60% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2019 and 21 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2019 was Wellington Management Group, an estimated $9.99M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2019 was Primecap Management, an estimated $36.8M sold.

Based on aggregated 13F filings for Q4 2019.